CMT-FFNet:一个基于CMT的特征融合网络,用于预测肝细胞癌中TACE治疗反应
Sen Wang1, Ying Zhao2, Xiuding Cai1
1Chengdu Institute of Computer Application Chinese Academy of Sciences, China; University of the Chinese Academy of Sciences, China.
概括
在肝细胞癌 (HCC) 中预测跨动脉化学血栓化 (TACE) 治疗反应至关重要. 使用多相MRI的新CMT-FFNet模型准确预测TACE的疗效,改善患者的治疗决策.
科学领域:
- 在瘤学瘤学.
- 放射学 放射学是一门学科.
- 人工智能的人工智能
背景情况:
- 肝细胞癌 (HCC) 是一种主要的肝癌.
- 超动脉化学栓塞 (TACE) 是一种常见的HCC治疗方法.
- 准确预测TACE反应对于个性化HCC管理至关重要.
研究的目的:
- 开发一种新的深度学习模型,用于预测HCC中TACE治疗反应.
- 利用多相磁共振成像 (MRI) 来提高预测的准确性.
主要方法:
- 一个基于卷积神经网络的特征融合网络 (CMT-FFNet) 被提出.
- 该模型使用注意力机制整合了本地和全球特征提取.
- 引入了对角性损失,以优化成像和临床数据的融合.
主要成果:
- CMT-FFNet有效地捕获了多相MRI数据和多式输入中的相关性.
- 该模型显示,TACE治疗反应的预测性能显著改善.
- 可视化技术确定了影响模型预测的关键区域.
结论:
- 拟议的CMT-FFNet模型显示了在HCC患者中准确预测TACE疗效的巨大潜力.
- 多相MRI与先进的人工智能相结合,为手术前治疗反应预测提供了一个有希望的方法.
- 这种方法可以帮助个性化治疗HCC的治疗策略.
相关概念视频
Targeted Cancer Therapies
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against specific...
There are several types of targeted therapies against specific...
Treatment Resistant Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
Treatment Resistent Cancers
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...


